Skripsi

HUBUNGAN ANTARA MINAT PENCARIAN GOOGLE TERKAIT VAKSINASI BOOSTER SERTA PENAMBAHAN KASUS COVID-19 DENGAN PEMBERIAN VAKSIN COVID-19 DOSIS KETIGA DI INDONESIA

---

Penilaian

---

Public interest and enthusiasm for the COVID-19 booster vaccination tends to be low, as seen from the coverage rate for booster vaccinations in Indonesia, which had only reached 25.84% on 31 August 2022. The immunity can decrease over time but there are also additional cases of COVID-19. Google Trends can be used as a monitoring tool for people's interests on the internet over time. This study aims to assess the relationship between public interest related to COVID-19 booster vaccination, especially for schedules, locations, and side related to the COVID-19 booster vaccination, especially for schedules, locations, and side effects and the addition of COVID-19 cases with the number of administration of the third dose of the COVID-19 vaccine in Indonesia. A mixed-method research approach with an explanatory design and cross-sectional was applied. Samples were taken by purposive sampling technique. Data analysis using Spearman Rho and with additional lag (+) analysis. The results showed that the highest search peaks were on March 24, 2022 for schedule and location keywords and March 30, 2022 for side effects. There is a significant correlation between searches for keywords related to booster vaccines (p

---

Availability

Inventory Code	Barcode	Call Number	Location	Status
2307002695	T11402	T1140202023	Central Library (Referens)	Available

Detail Information

Series Title

-

Call Number

T1140202023

Publisher

Indralaya : Prodi Kesehatan Masyarakat, Fakultas Kesehatan Masyarakat Universitas Sriwijaya., 2023

Collation

xiv, 75 hlm.; ilus.; 29 cm

Language

Indonesia

ISBN/ISSN

-

Classification

614,407

Content Type

Text

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Prodi Kesehatan Masyarakat
Imunisasi- Vaksinasi-Covid-19

Specific Detail Info

-

Statement of Responsibility

MURZ

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment